Advisory Services Network’s AnaptysBio ANAB Stock Holding History

Advisory Services Network’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3	Closed	-$166	–	2265
2026 Q1	$166	Buy	+3	New	+$161	﹤0.01%	4599
2025 Q4	–	Sell	-3	Closed	-$92	–	1900
2025 Q3	$92	Buy	+3	New	+$69	﹤0.01%	4378
2023 Q2	–	Sell	-230	Closed	-$5K	–	1521
2023 Q1	$5K	Hold	230	–	–	﹤0.01%	3152
2022 Q4	$7.13K	Buy	+230	New	+$6.5K	﹤0.01%	2993

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Advisory Services Network's ANAB Position: Q2 2026 in Review

Advisory Services Network sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 3 shares — an estimated $166 sold.

Advisory Services Network first reported a position in ANAB in Q4 2022 and held it in 4 quarters. The position peaked at $7.13K in Q4 2022. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Advisory Services Network reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 3 AnaptysBio shares in Q2 2026, an estimated $166.
Advisory Services Network first reported a position in AnaptysBio in Q4 2022 and held it in 4 quarters.
Advisory Services Network's AnaptysBio position peaked at $7.13K in Q4 2022.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.